Course Objectives

  • Review the “true data” from the WHI, with the significant outcomes that impact our treatment of women in relation to HRT replacement therapy

  • Learn the importance of testosterone in breast health, as well as its implications in treating women with history of or active breast cancer

  • Discuss the different treatment options for Genitourinary Symptoms of Menopause, as well as the safe treatment options for breast cancer patients

  • Learn which BHRT options may be safe and effective in breast cancer patients or those with a high-risk background or history

Course curriculum

    1. Welcome to Management Considerations for Patients with Risk Of or Diagnosis Of Breast Cancer

    1. Breast Cancer Risks and Development lecture (36:13)

    2. Breast Cancer Risks and Development- PDF

    1. Genitourinary Syndromes and Possible Treatments for Best Outcomes lecture (12:57)

    2. Genitourinary Syndromes and Possible Treatments for Best Outcomes- PDF

    1. Management Strategies lecture (26:59)

    2. Management Strategies- PDF

    1. Glaser 2021-Testosterone Implant Therapy in Women With and Without Breast Cancer: Rationale, Experience, Evidence

    2. Chelbowski 2021-Breast Cancer Prevention: Time for a Change

    3. Glaser 2013- Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole:A prospective, observational study

    4. Tan 2022- Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk

    5. Glaser 2019- Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study

    6. Hodis 2018-Menopausal hormone therapy and breast cancer what is the evidence from randomized trials

    7. Feng 2018- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

    8. Donovitz 2021- Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study

    9. Longer 2017-What Are We To Believe

    1. Breast Cancer Management Quiz

About this course

  • $399.00
  • 17 lessons
  • 1.5 hours of video content

Instructor(s)

Angela DeRosa DO, MBA, CPE

America's Hormone Doctor™, Dr. Angela DeRosa, DO, MBA, CPE, is a world-renowned expert in hormonal health, recognized for her groundbreaking advancements and ongoing contributions to the field of bioidentical hormone replacement therapy (BHRT) and integrative medicine. With a career that spans several decades and a reach that has touched providers coast to coast as well as in China, Japan, the UAE, Australia, Moscow, Great Britain, and Canada, to name a few, Dr. DeRosa has established herself as an international leader and authority in the field. Her journey into hormonal medicine was catalyzed by her personal struggle with undiagnosed menopause at age 35, igniting a mission to revolutionize care for patients experiencing hormonal imbalances. While having treated over 10,000 patients personally, Dr DeRosa wanted to do more. To that end, in 2018, she founded the Hormonal Health Institute (HHI) that not only provides highly customized training solutions for the individual provider but is also the only training organization offering comprehensive, turnkey BHRT training and practice development for larger scale medical organizations. Dr. DeRosa serves on multiple boards, including the Board of Directors at Belmar Pharma Solutions as their Medical Director, the Arizona Osteopathic Medical Association and as a member of the Medical Advisory Board of the European Menopause and Andropause Society. Her previous roles include serving on the Board of Directors for the American Osteopathic Foundation and as Senior Medical Director for Procter & Gamble Pharmaceuticals, where she led strategic initiatives in women’s health. An author (A Woman’s Health Survival Guide) and published researcher, Dr. DeRosa is also a Clinical Assistant Professor at Midwestern University and the University of Arizona College of Medicine–Phoenix. She is proud to be affiliated with leading organizations in the field such as the Member of International Menopause Society, the Women’s Health Advisory Panel, The Longevity Docs Club amongst others. Dr. DeRosa resides in Scottsdale, Arizona, where, as a sought-after lecturer, advisor, and practitioner, she continues to advance global standards in hormonal healthcare, driven by her passion for patient care, innovation, and excellence. Dr. Angela DeRosa, Medical Director for Belmar Pharma Solutions is a respected, internationally recognized authority on women’s hormonal health. Dr. DeRosa has more than 25 years of experience in pharmaceuticals, clinical practice, and education. A board-certified internist specializing in women’s health and hormonal health for men and women, Dr. DeRosa is the Founder of DeRosa Medical, DRM Integrative Health, and Revive Wellness, where she treated over twenty thousand patients using advanced BHRT optimization. Dr. DeRosa is also an accomplished author, professor, lecturer, and published researcher as well as the founder of the Hormonal Health Institute. Dr. DeRosa received a Doctorate of Osteopathic Medicine from Midwestern University as well as a Master’s in Medical Management from Amherst College.